Good piece on Loxo Oncology's drug Vitrakvi which was approved yesterday and carries nearly a $400K annual price target. It was also the 53rd drug approved by the FDA this year, tying an all-time record that has stood since 1996. New leadership at the government agency is really speeding up the drug approval process....

Comments


Bret Jensen
EditorBret Jensen
Bret Jensen
EditorBret Jensen
Bret Jensen
EditorBret Jensen